BOSTON and GLASGOW, Scotland, Sept. 12, 2023 /PRNewswire/ Dewpoint Therapeutics and Chemify today announced a partnership to develop a suite of digitally discovered and automatically synthesized novel molecules on
/PRNewswire/ A new perspective published in Nature Reviews Drug Discovery examines the potential of biomolecular condensates to transform drug discovery..
/PRNewswire/ A new perspective published in Nature Reviews Drug Discovery examines the potential of biomolecular condensates to transform drug discovery..
/PRNewswire/ Dewpoint Therapeutics, Inc. today announced biomolecular scientist Anthony Hyman, head of the Max Planck Institute of Molecular Cell Biology.